The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
Global Phase-3 study initiation expected in the second half of 2024
Sun Pharma's Dadra facility receives OAI status from US FDA
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Both organisations enter into a long- term collaboration to expand patient access in India
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
